2025-05-29 - Analysis Report
Okay, here's an analysis of Transmedics Group Inc (TMDX) based on the provided data.

**Report: Transmedics Group Inc (TMDX) Analysis**

Transmedics Group Inc (TMDX) is a medical technology company focused on organ preservation and transplantation.

**1. Performance Relative to S&P 500 (VOO)**

*   **TMDX Cumulative Return:** 251.14%
*   **VOO Cumulative Return:** 53.45%
*   **Absolute Divergence:** 197.7%
*   **Relative Divergence:** 73.9% (This indicates TMDX's outperformance is positioned at the 73.9th percentile of its historical divergence range vs. VOO.)

**Alpha/Beta Analysis:**

| Year       | CAGR   | MDD    | Alpha   | Beta   | Cap(B) |
|------------|--------|--------|---------|--------|--------|
| 2019-2021  | -4.0%  | 63.4%  | -57.0%  | 0.0    | 0.7    |
| 2020-2022  | 140.0% | 68.3%  | 134.0%  | 0.0    | 2.1    |
| 2021-2023  | 95.0%  | 69.4%  | 79.0%   | 0.3    | 2.7    |
| 2022-2024  | 147.0% | 82.8%  | 130.0%  | 0.3    | 2.1    |
| 2023-2025  | 132.0% | 82.8%  | 103.0%  | 0.5    | 4.3    |

**Analysis:**

*   TMDX has significantly outperformed the S&P 500 (VOO) over the specified period.
*   The positive Alpha values across the years show that TMDX has consistently outperformed the market on a risk-adjusted basis.
*   The Beta values, generally below 1, suggest that TMDX has been less volatile than the market. However, the recent Beta of 0.5 indicates increasing correlation with the market.
*   High Maximum Drawdown (MDD) values suggest the stock is prone to significant declines.
*   The CAGR (Compound Annual Growth Rate) is exceptionally high in recent periods, indicating rapid growth.

**2. Recent Stock Price Movement**

*   **Current Price:** 128.62
*   **Previous Close:** 128.53
*   **Change:** 0.07
*   **5-day Moving Average:** 125.21
*   **20-day Moving Average:** 111.90
*   **60-day Moving Average:** 87.39

**Analysis:**

*   The price is above all three moving averages (5, 20, and 60-day), indicating a strong uptrend.
*   The slight positive change from the previous close suggests continued momentum.

**3. Technical Indicators & Signals**

*   **Market Risk Indicator (MRI):** 0.37 (Low Risk)
*   **RSI:** 85.36 (Overbought)
*   **PPO:** -0.1381
*   **Hybrid Signal:** cash_0%_Buy 80% of cash (1 shares - Caution - MRI:0.37)
*   **20-day Relative Divergence Change:** 3.4 (+) (Short-term increase)
*   **Expected Return:** 37.1% (Long-term, relative to S&P 500)

**Analysis:**

*   The MRI suggests a low-risk environment, but the RSI is in overbought territory, indicating a potential pullback.
*   The PPO close to 0 suggests a slightly underbought condition of short-term momentum compared to long-term momentum.
*   The hybrid signal suggests a Buy with caution due to the MRI, indicating a mixed outlook.
*   The positive change in relative divergence supports the short-term upward trend.
*   The high expected return is attractive for long-term investors.

**4. Recent News & Significant Events**

*   **2025-05-28:** Major business developments, regulatory changes, or market events.
*   **2025-05-26:** Analyst discussions on recent performance and outlook.
*   **2025-05-29:** Stock volatility due to recent news, earnings, or executive actions.
*   **2025-05-27:** Market experts highlight risks and opportunities.

**Analysis:**

*   Recent news suggests increased volatility and potential catalysts (both positive and negative) affecting TMDX. Investors should monitor company announcements closely.

**5. Recent Earnings Analysis**

| Date       | EPS  | Expected EPS |
|------------|------|--------------|
| 2025-05-08 | 0.70 | 0.29         |
| 2025-02-27 | 0.19 | 0.22         |
| 2024-10-28 | 0.12 | 0.29         |
| 2024-07-31 | 0.35 | 0.21         |
| 2024-04-30 | 0.35 | 0.03256      |

**Analysis:**

*   TMDX has exceeded earnings expectations in the most recent quarter (2025-05-08).  However, the results were mixed in previous quarters, with some misses. The consistent outperformance of EPS compared to expectations in 2024 and 2025-05-08 are positive signals, although the one miss in 2025-02-27 indicates a bit of volatility.

**6. Financial Information**

**Revenue and Profitability:**

| Quarter    | Revenue | Profit Margin |
|------------|---------|---------------|
| 2025-03-31 | $0.14B  | 61.47%        |
| 2024-12-31 | $0.12B  | 59.21%        |
| 2024-09-30 | $0.11B  | 55.94%        |
| 2024-06-30 | $0.11B  | 60.59%        |
| 2024-03-31 | $0.10B  | 61.91%        |

**Capital and Profitability:**

| Quarter    | Equity  | ROE   |
|------------|---------|-------|
| 2025-03-31 | $0.27B  | 9.64% |
| 2024-12-31 | $0.23B  | 3.00% |
| 2024-09-30 | $0.21B  | 2.01% |
| 2024-06-30 | $0.19B  | 6.42% |
| 2024-03-31 | $0.16B  | 7.65% |

**Analysis:**

*   Revenue is consistently growing.
*   Profit margins are exceptionally high, indicating strong pricing power and efficient operations.
*   Equity is increasing, reflecting retained earnings and financial health.
*   ROE (Return on Equity) is volatile but generally positive and strong, particularly in the most recent quarter.

**7. Overall Analysis & Conclusion**

TMDX is a high-growth stock with significant outperformance compared to the S&P 500. The company exhibits strong revenue growth, high profit margins, and a healthy financial position. Recent earnings have generally exceeded expectations.

**However, several factors warrant caution:**

*   **High Volatility:** The high MDD and recent news-driven volatility suggest that the stock is prone to significant price swings.
*   **Overbought RSI:** The overbought RSI indicates a potential pullback in the short term.
*   **Beta:** Although Beta has historically been low, recent data suggests an increasing correlation with the market.
*   **Hybrid Signal:** Mixed buy signal

**Recommendation:**

TMDX appears to be a potentially rewarding investment for long-term investors seeking growth. However, investors should be aware of the inherent risks associated with high-growth stocks and monitor the company's performance, news, and market conditions closely. A diversified portfolio and a long-term investment horizon are recommended. Consideration should be given to waiting for a pullback before establishing or adding to a position, given the overbought RSI.
